Healthcare Industry - Medical - Pharmaceutical - Biotech in Amsterdam, Netherlands

Radioligand therapy is evolving rapidly. With new targets like HER2 and FAP coming into focus, and promising data emerging beyond PSMA and SSTR2, there's real momentum building in the field. But to fully unlock the potential of these therapies across Europe, and to i ..

The Pharma and Biotech Patent Litigation Track at the Patent Litigation Europe Summit 2026 is the leading European forum for life sciences IP counsel and litigators to benchmark enforcement strategies, navigate evolving UPC case law, and prepare for the next wave of ..

BioClina 2026 – International Conference on Biological & Clinical Studies, 20-21 February, Amsterdam Conference Name: BioClina 2026 – International Conference on Biological & Clinical Studies, 20-21 February, Amsterdam Conference Dates: 20-21 February 2026 Con ..

The "10th International Conference on Future Pharma and Innovations," scheduled for September 23-24, 2025, in Amsterdam, Netherlands, and largely focused on the theme "Innovations in Pharma: Pioneering the Future of Healthcare" is cordially invited to participants fr ..

It is pleasure to invite you to attend the 23rd IAGG World Conference in Amsterdam, July 5-8 2026, on behalf of the International Association of Gerontology and Geriatrics, the Dutch Society for Gerontology (NVG-KNOWS), the Netherlands Clinical Geriatrics Society (NV ..

2024 saw a wealth of clinical progression with Nouscom, CureVac, Transgene and other pioneering companies paving the way for neoantigen based vaccines and therapies to become tolerable, durable medicines to effectively treat cancer. Ready to unite the global neoan ..

As regulators and payers increasingly elevate the importance of RWE in submission requirements and with an explosion of datasets opening up in parallel with advancing AI, deep learning, and large language models transforming big data analysis, it has never been more ..

Fortunately, new developments occur rapidly in all involved disciplines. New Gastroenterology techniques lead to earlier detection and better endoscopic treatment. New Radiology features lead to better staging, whereas new Surgical techniques, like sentinel node, lap ..

Compared to five years ago, biopharma lab operations have undergone a transformation driven by tighter budgets, technological advancements, and the need for greater efficiency. Organisations today are focused on digitisation, automation, and sustainability while opti ..

We are thrilled to extend a warm welcome to the 18th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD 2025), scheduled to take place from 19-22 March, 2025, in Amsterdam, The Netherlands. We invite you to join us at ATTD, the pre ..

This year has been the year for radiopharmaceuticals, with market projections estimating to grow to $39 billion by 2032. More patients are being treated by Pluvicto and Lutathera than ever before, companies advancing their pipelines across a range of targeting moieti ..

Brought to you by HMP Global and GTGL Global Events Ltd, AMP Europe is an expansion of the Amputation Prevention Symposium (AMP), the flagship meeting taking place annually in August in Chicago and now in its 14th year. AMP is an unrivaled CME meeting focused on the ..

The last 12 months have highlighted key milestones in European biopharma investment– from GSK injecting €1 million into a 15-building biotech campus in Stevenage, to AstraZeneca investing £1 billion into a new R AND D and Corporate HQ. As the pressure to expand and c ..

With the EMA's guidance on the use of real world evidence in its regulatory decision-making, and federated learning networks that continue to support pharma, the integration of real world evidence into clinical research is transforming drug development. Following ..